News | Controlled Release Society (CRS)

Advertise Here Submit an Article Subscribe to All News Subscribe to Current News Category

Patent Watch

Authors:

This article briefly summarizes novel aspects of selected United States (U.S.) patents involving controlled release or delivery that were issued from July 1 to December 31, 2015. Greater detail on each can be found on the U.S. patent website at…

Drug Delivery and Translational Research Update

CRS Premeeting Workshop on the Regulatory Landscape for Therapeutic Biologics

Authors:

PuraCap Pharmaceutical

Overview While some biologics are intended to treat diseases and medical conditions, others are designed to prevent or diagnose diseases. The therapeutic biological products (TBPs) regulated by the Center for Drug Evaluation and Research (CDER) of the U.S. FDA typically refer to the following…

How the First Young Israeli Controlled Release Society (YICRS) Conference Was Established

Authors:

Assaf Zinger, Technion, Israel

My name is Assaf Zinger, and I am a Ph.D. student in Avi Schroeder’s lab at the Technion, Israel. I’d like to share with you the story of the first YICRS conference. So, like…

CRS Premeeting Workshop on the Regulatory Landscape for Therapeutic Biologics

Authors:

PuraCap Pharmaceutical

Patterned Nanoporous Polypyrrole for Tunable Ocular Drug Delivery

Authors:

Ali Seyfoddin, Hongrui Zhang, Simon Moulton, Michael Higgins, Michael Higgins, Geoff Waterhouse, Darren Svirskisa

IntroductionCorticosteroids such as dexamethasone are the first line of treatment for noninfectious posterior uveitis and are also routinely used for the treatment of age-related macular degeneration (AMD) (Figure 1…